Searchable abstracts of presentations at key conferences in endocrinology

ea0062wh9 | Workshop H: Miscellaneous endocrine and metabolic disorders | EU2019

A challenging case of chronic hyponatraemia

Galloway Iona , Garrahy Aoife , Sherlock Mark , Thompson Christopher

A 56-year-old male presented in 2017 with acute symptomatic hyponatraemia. He was admitted with a seizure and a plasma sodium of 112 mmol/l. His past medical history was notable for alcohol excess and smoking. The acute presentation was managed with 3% hypertonic saline infusion in ITU. Plasma osmolality was 240 mOsm/Kg, urine osmolality 327 mOsm/kg and sport urine sodium 28 mmol/l. CT TAP showed some oesophageal thickening only; endoscopy was normal. He made a good recovery f...

ea0049ep877 | Endocrine tumours and neoplasia | ECE2017

Intrasellar malignant haemangiopericytoma: a rare case

Omer Tahir , Tauni Rahat , Gurnell Mark , Kolouri Olympia

We report a case of malignant hemangiopericytoma in sellar region in a 73-year-old lady who initially presented with symptomatic hyponatraemia. She was found to have hypocortisolism on short synacthen test. She was treated with hydrocortisone and was found to have secondary hypothyroidism. Her gonadotropin levels were commensurate with menopause, prolactin levels were normal and there was no suggestion of diabetes insipidus. Initial pituitary magnetic resonance imaging (MRI) w...

ea0049ep1312 | Thyroid (non-cancer) | ECE2017

Treatment choice and patient satisfaction in thyrotoxicosis

Conaglen Helen , Tamatea Jade , Swarbrick Mark , Conaglen John , Elston Marianne

Background: Thyrotoxicosis may be associated with considerable patient morbidity. Graves’ disease (GD) and toxic multinodular goitre (TMNG) are the most common causes of thyrotoxicosis. Therapeutic options include anti-thyroid medication or definitive treatment by radioiodine or surgery. Efficacy, quality of life and cost-effectiveness are among the outcomes that have been compared between these two therapies. However, there is still no clear consensus as to which treatme...

ea0044oc3.5 | Thyroid and Neoplasia | SFEBES2016

Identification of murine neuroendocrine tumour (NET) cell binding peptides identified through phage display

Stevenson Mark , Javid Mahsa , Lines Kate , Thakker Rajesh

Neuroendocrine tumours (NETs) may occur in multiple sites including, the pancreas, gastrointestinal tract, lung, thymus, adrenals and pituitary, and as part of the multiple endocrine neoplasia type 1 (MEN1) syndrome. Current treatments for advanced NETs, rarely achieve a cure due to metastases at presentation and therefore additional treatments are required. Identification of cell surface receptors or binding sites that are unique to NETs could lead to novel targeted drugs, ra...

ea0044p38 | Adrenal and Steroids | SFEBES2016

18F-FDG PET-CT combined with 11C-metomidate PET-CT for the successful characterisation of adrenal lesions; proof of utility of a novel imaging strategy in guiding management

Powlson Andrew S , Koulouri Olympia , Cheow HK , Gurnell Mark

Background/aims/method: Evaluation/management of adrenal incidentalomas (AI) is an increasingly prevalent challenge. CT/MRI characteristics may be useful in determining whether a lesion is a benign adenoma and forthcoming ESE-ENSAT guidance suggests a role for 18F-FDG-PET/CT in distinguishing benign vs malignant lesions. We have previously demonstrated the utility of 11C-metomidate (MTO), which binds CYP11B1/B2, in localising aldosterone-producing adenoma...

ea0044p122 | Neoplasia, cancer and late effects | SFEBES2016

Investigation of the effects and interactions of a human neuroendocrine tumour (NET) cell binding peptide

Stevenson Mark , Lines Kate , Thomas Benjamin , Thakker Rajesh

Pancreatic neuroendocrine tumours (PNETs) may occur as part of the multiple endocrine neoplasia type 1 (MEN1) syndrome or as non-familial (sporadic) tumours. PNETs, which include gastrinomas, insulinomas and non-functioning tumours occur in more than 80% of MEN1 patients and account for 50% of disease-specific deaths. This is because 25–40% of patients with PNETs will have metastasis at presentation, and current treatments, which include surgery, chemotherapy and radiothe...

ea0044ep75 | (1) | SFEBES2016

The challenges to diagnose and differentiate TSHoma from thyroid hormone resistance: a case report

Hamdan Khaliq , Koulouri Olympia , Gurnell Mark , Chatterjee Krishna , Owen Penelope

TSHoma is rare, with an incidence of 1 per million, and <1% of all pituitary tumours. We reported a case involving a 49-year-old female who was first referred to our endocrine unit in 2006 with excessive lethargy and abnormal TFT’s. She was thought to have thyroid hormone resistance for several years until 2015 when she reported having persistent symptoms and further investigation suggested an alternative diagnosis.Results: Ft4=41.6 pmol/l, TSH=...

ea0042p35 | (1) | Androgens2016

Isolation, propagation and characterisation of primary prostate cancer epithelial cell lines from prostate specimens

Patek Samantha , McCall Pamela , Underwood Mark A , Edwards Joanne

Prostate cancer is the most common male cancer in the UK. Currently there is a lack of pre-clinical models to predict patient’s response to treatment for prostate cancer. Identifying which patients will respond best to treatment avoids exposing patients to treatment side effects unnecessarily. Primary cell culture provides a translational model to predict individual patient’s response to drug treatments. In this study, we develop a technique for isolation, propagatio...

ea0039ep81 | Miscellaneous/other | BSPED2015

Pilot study on the utility and acceptability of video animation as a delivery method for educational materials for families and carers of patients with congenital hyperinsulinism in infancy

Rodgers Elizabeth , Rigby Lindsey , Dunne Mark , Banerjee Indraneel , Cosgrove Karen

Introduction: To prevent neurological damage caused by congenital hyperinsulinism (CHI), hypoglycaemia must be avoided and treated promptly. Education of parents, carers and families of patients with CHI (PCFs) about the causes and consequences of CHI may help to reduce severity of hypoglycaemia due to earlier correction of blood glucose levels. We aimed to determine whether video animations could be used to improve understanding of CHI among PCFs, and the acceptability of thi...

ea0059p211 | Thyroid | SFEBES2018

Ultrasonographic features and management of thyroid nodules undergoing ultrasound-guided fine needle aspiration

Attard Carol Cardona , Psaila Alison , Buttigieg Lisa , Gruppetta Mark

Introduction: Thyroid nodules can be detected in 50 to 60% of healthy individuals, particularly in the elderly and females. An increase in differentiated thyroid cancer has been noted over the years, especially papillary thyroid cancer.Objectives: To assess different approaches to management and histological nature of thyroid nodules in Malta, as well as to evaluate the association of ultrasound characteristics with biochemical and histological features....